Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$6.38 - $18.33 $159,525 - $458,323
-25,004 Reduced 45.46%
29,996 $331,000
Q1 2022

May 16, 2022

SELL
$12.38 - $19.1 $183,979 - $283,845
-14,861 Reduced 21.27%
55,000 $916,000
Q4 2021

Feb 14, 2022

SELL
$16.55 - $27.63 $85,050 - $141,990
-5,139 Reduced 6.85%
69,861 $1.33 Million
Q3 2021

Nov 15, 2021

BUY
$20.35 - $26.63 $184,472 - $241,400
9,065 Added 13.75%
75,000 $1.85 Million
Q2 2021

Aug 16, 2021

BUY
$16.33 - $33.07 $569,492 - $1.15 Million
34,874 Added 112.28%
65,935 $1.72 Million
Q1 2021

May 14, 2021

BUY
$28.67 - $52.59 $342,205 - $627,714
11,936 Added 62.41%
31,061 $983,000
Q4 2020

Feb 16, 2021

SELL
$28.04 - $50.26 $600,785 - $1.08 Million
-21,426 Reduced 52.84%
19,125 $887,000
Q3 2020

Nov 16, 2020

BUY
$27.75 - $36.3 $40,653 - $53,179
1,465 Added 3.75%
40,551 $1.34 Million
Q2 2020

Aug 14, 2020

BUY
$27.21 - $41.0 $274,440 - $413,526
10,086 Added 34.78%
39,086 $1.07 Million
Q1 2020

May 15, 2020

SELL
$19.54 - $38.85 $39,080 - $77,700
-2,000 Reduced 6.45%
29,000 $868,000
Q4 2019

Feb 14, 2020

BUY
$17.95 - $29.41 $206,425 - $338,215
11,500 Added 58.97%
31,000 $858,000
Q3 2019

Nov 14, 2019

BUY
$17.99 - $26.0 $350,804 - $507,000
19,500 New
19,500 $355,000

Others Institutions Holding IOVA

About IOVANCE BIOTHERAPEUTICS, INC.


  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $1.28B
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Weiss Multi Strategy Advisers LLC Portfolio

Follow Weiss Multi Strategy Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.